← Leaderboards
Evanthia Theodosiou Roussos Torres
University Of Southern California
$2,679,821
Attributed
$2,945,667
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2023–25$2M$1.5M$1M$500K$0
'23
'24
'25
Funding mix
By agency
NIH$3,747,019 · 5
By mechanism
R01$1,678,974 · 1
P20$1,536,352 · 3
U01$531,693 · 1
Top collaborators
- Stacey Deleria Finley1 shared
Most similar at University Of Southern California
Same institution · by research overlap
- Jeffrey S Weber$20,866,039
- W Martin Kast$9,478,408
- Rongfu Wang$19,053,396
- Kelly A Musick$2,036,521
- Jill E Johnston$9,638,937
Others in their field
Other Rising Stars on “Response”
- Katherine M Thibault · Battelle Memorial Institute$134,148,552
- Angee Greer · Ppd Development Lp$82,531,927
- Richard Smith · Medical Device Innovation Consortium$41,401,350
- Rhea Coler · Seattle Children'S Hospital$35,184,139
- Julia Louise Moore Vogel · Scripps Research Institute, The$32,252,685
- Bridget Murphy · Broad Institute, Inc.$23,600,775
Research focus
ResponseCellsImmunosuppressionImmuneMalignant Breast NeoplasmTumor MicroenvironmentTreatment ResponseMyeloid-Derived Suppressor CellsMalignant NeoplasmsResistanceClinical TrialsCheckpoint InhibitionBreast Cancer PatientInfiltrationComplexHistone Deacetylase InhibitorNivolumabTumorIpilimumabT-LymphocyteAntitumor ResponseFlow CytometryFutureAnti-Cancer Research
Grant awards (10)
Targeting myeloid suppression to enhance anti-tumor immunity in breast cancer$562,338
R01 · FY2025 · CA · contact PI
Exploring the dynamic tumor-immune ecosystem of breast cancer in heterogeneous tumor microenvironments$531,693
U01 · FY2025 · CA
The role of immunosuppression in the tumor microenvironment and association with social drivers of health in patients with breast cancer$425,717
P20 · FY2025 · CA · contact PI
The role of immunosuppression in the tumor microenvironment in Hispanic/Latino patients with breast cancer$267,770
P20 · FY2025 · CA · contact PI
The role of immunosuppression in the tumor microenvironment in Hispanic/Latino patients with breast cancer$91,595
P20 · FY2025 · CA · contact PI
Targeting myeloid suppression to enhance anti-tumor immunity in breast cancer$536,866
R01 · FY2024 · CA · contact PI
The role of immunosuppression in the tumor microenvironment in Hispanic/Latino patients with breast cancer$375,635
P20 · FY2024 · CA · contact PI
The role of immunosuppression in the tumor microenvironment in Hispanic/Latino patients with breast cancer$285,605
P20 · FY2024 · CA · contact PI
The role of immunosuppression in the tumor microenvironment in Hispanic/Latino patients with breast cancer$90,030
P20 · FY2024 · CA · contact PI
Targeting myeloid suppression to enhance anti-tumor immunity in breast cancer$579,770
R01 · FY2023 · CA · contact PI